share_log

Deutsche Bank Initiates Coverage On Neumora Therapeutics With Hold Rating, Announces Price Target of $13

Deutsche Bank Initiates Coverage On Neumora Therapeutics With Hold Rating, Announces Price Target of $13

德意志银行以持有评级启动对Neumora Therapeutics的报道,宣布目标股价为13美元
Benzinga ·  2023/12/12 05:06

Deutsche Bank analyst Neena Bitritto-Garg initiates coverage on Neumora Therapeutics (NASDAQ:NMRA) with a Hold rating and announces Price Target of $13.

德意志银行分析师Neena Bitritto-Garg以持有评级开始对Neumora Therapeutics(纳斯达克股票代码:NMRA)进行报道,并宣布目标股价为13美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发